Abstract C222: Voreloxin is synergistic in in vitro combination with cytarabine and additive in combination with azacitidine, decitabine, and clofarabine
Stockett, David E., Kumer, Jeffrey L., Scatena, Carrie D., Silverman, Jeffrey A., Hawtin, Rachael E., Fox, Judith A.
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article